These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30683443)

  • 1. Interest of pharmacoepidemiology for the study of anticoagulants.
    Bagheri H
    Therapie; 2019 Apr; 74(2):245-248. PubMed ID: 30683443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
    Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
    Yoshihisa A; Sato Y; Sato T; Suzuki S; Oikawa M; Takeishi Y
    BMC Cardiovasc Disord; 2018 Jan; 18(1):11. PubMed ID: 29368593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the Characteristics of Patients Experiencing Adverse Drug Reactions to Oral Anticogulants and How Can Such Reactions be Prevented?
    Spada G; Vighi GV; Pagani S; Vighi GD; Venegoni M; Ruocco M
    Curr Drug Saf; 2020; 15(1):38-44. PubMed ID: 31580253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal Agents for the Direct Oral Anticoagulants.
    Ansell JE
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1085-98. PubMed ID: 27637309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Direct oral anticoagulants and drug-drug interactions].
    Graf L; Korte W
    Ther Umsch; 2015 Feb; 72(2):99-104. PubMed ID: 25630291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current challenges and future prospects in oral anticoagulant therapy.
    Czuprynska J; Patel JP; Arya R
    Br J Haematol; 2017 Sep; 178(6):838-851. PubMed ID: 28573648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulants.
    McGlasson DL
    Clin Lab Sci; 2004; 17(2):107-12. PubMed ID: 15168892
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis.
    Hum J; Shatzel JJ; Jou JH; Deloughery TG
    Eur J Haematol; 2017 Apr; 98(4):393-397. PubMed ID: 28009449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vitamin K antagonist, direct oral anticoagulants: Where is the truth?].
    Laroche JP; Schved JF
    J Mal Vasc; 2016 Dec; 41(6):383-388. PubMed ID: 27817997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Discontinuing oral anticoagulation for elective surgical interventions].
    Marzan A; Ulrich Somaini S; Bächli E
    Praxis (Bern 1994); 2011 Nov; 100(23):1387-92; quiz 1393-5. PubMed ID: 22086376
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants.
    Chan NC; Eikelboom JW; Weitz JI
    Circ Res; 2016 Apr; 118(9):1409-24. PubMed ID: 27126650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on general measures.
    Di Fusco SA; Lucà F; Benvenuto M; Iorio A; Fiscella D; D'Ascenzo F; Madeo A; Colivicchi F; Di Lenarda A; Gulizia MM
    Int J Cardiol; 2018 Oct; 268():80-84. PubMed ID: 29853278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
    Pritchard ER; Murillo JR; Putney D; Hobaugh EC
    J Oncol Pharm Pract; 2019 Jan; 25(1):52-59. PubMed ID: 28825375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of direct oral anticoagulant and vitamin K antagonists on outcomes among elderly and nonelderly trauma patients.
    Nishimura T; Guyette FX; Naito H; Nakao A; Brown JB; Callaway CW
    J Trauma Acute Care Surg; 2020 Sep; 89(3):514-522. PubMed ID: 32544105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead?
    Cohen AT; Granziera S; Veronese N; Zoppellaro G
    Semin Respir Crit Care Med; 2017 Feb; 38(1):29-39. PubMed ID: 28208196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct oral anticoagulants and bleeding risk (in comparison to vitamin K antagonists and heparins), and the treatment of bleeding.
    Palareti G
    Semin Hematol; 2014 Apr; 51(2):102-11. PubMed ID: 24861794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome.
    Sciascia S; Lopez-Pedrera C; Cecchi I; Pecoraro C; Roccatello D; Cuadrado MJ
    Rheumatology (Oxford); 2016 Oct; 55(10):1726-35. PubMed ID: 26843482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major Bleeding and Hemorrhagic Stroke With Direct Oral Anticoagulants in Patients With Renal Failure: Systematic Review and Meta-Analysis of Randomized Trials.
    Raccah BH; Perlman A; Danenberg HD; Pollak A; Muszkat M; Matok I
    Chest; 2016 Jun; 149(6):1516-24. PubMed ID: 26836922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.